MBD and Azothbio partner for rare cancer drug using AI modeling technology March 3, 2020 By Jihyun Kim No Comments HONG KONG – MBD Co. Ltd. and Azothbio Inc., both based in South Korea, have entered an agreement for rare cancer drug development using an AI-powered drug discovery platform.Read More